Abstract
Nine patients with SLE-associated neutropenia and infections received 48 Mio U G-CSF per day s.c. for 2-17 days as an adjunct to antibiotic treatment. Granulopoiesis was normal or hyperplastic in all cases. The mean granulocyte count increased within 2 days from 1.4 per nl to 11.4 per nl. Side-effects were exacerbating CNS symptoms in two patients and a case of leukocytoclastic vasculitis. G-CSF induced constantly a rapid and distinct increase of neutrophil granulocytes in lupus-associated neutropenia patients with normo- or hyperplastic granulopoiesis.
MeSH terms
-
Adult
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Granulocyte Colony-Stimulating Factor / administration & dosage*
-
Granulocytes / drug effects
-
Granulocytes / immunology
-
Humans
-
Injections, Subcutaneous
-
Leukocyte Count / drug effects
-
Lupus Erythematosus, Systemic / immunology
-
Lupus Erythematosus, Systemic / therapy*
-
Male
-
Neutropenia / immunology
-
Neutropenia / therapy*
-
Neutrophils / drug effects
-
Neutrophils / immunology
-
Opportunistic Infections / immunology
-
Opportunistic Infections / therapy*
Substances
-
Granulocyte Colony-Stimulating Factor